Chemistry and reactivity of acyl glucuronides

Current Drug Metabolism

Volumn 12, Issue 3, 2011, Pages 215-221

  Stachulski, Andrew V ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acyl migration; Carbohydrate synthesis; Drug metabolism; Drug toxicity; Glucuronides; Protein reactivity

Indexed keywords

ACYL GLUCURONIDE; BENZOIC ACID; DICLOFENAC; GLUCURONIDE; HYDROLASE; IBUPROFEN; MYCOPHENOLIC ACID; PROTEIN; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BIOGENESIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG INDUSTRY; DRUG SUBSTITUTION; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY;

ACYLATION; GLUCURONIDES; HUMANS; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; PROTEINS;

EID: 79953661890     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795101822     Document Type: Article

References (55)

1. Juteau, H.; Gareau, Y.; Labelle, M. A convenient synthesis of β- acyl glucuronides. Tetrahedron Lett., 1997, 38(9), 1481-1484.
2. Perrie, J. A.; Harding, J. R.; Holt, D. W.; Johnston, A.; Meath, P.; Stachulski, A. V. Effective synthesis of 1β-acyl glucuronides by selective acylation. Org. Lett., 2005, 7(13), 2591-2594. (Pubitemid 43034215)
3. Bowkett, E. R.; Harding, J. R.; Maggs, J. L.; Park, B. K.; Perrie, J. A.; Stachulski, A. V. Efficient synthesis of 1β-acyl glucuronides via selective acylation of allyl or benzyl glucuronate. Tetrahedron, 2007, 63(32), 7596-7805.
4. Berry, N. G.; Iddon, L. ; Iqbal, M.; Meng, X.; Jayapal, P.; Stachulski, A. V.; Johnson, C. H.; Nicholson, J. G.; Lindon, J. C. ; Harding J. R. ; Wilson, I. D. Synthesis, transacylation kinetics and computational chemistry of a set of arylacetic acid 1β-O-acyl glucuronides. Org. Biomol. Chem., 2009, 7(12), 2525-2533.
5. Boelsterli, U. A. Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions. Curr. Drug Metab., 2002, 3(4), 439-450. (Pubitemid 34778006)
6. Sakaguchi, K.; Green, M.; Stock, N.; Reger, T. S.; Zunic, J.; King, C. Glucuronidation of carboxylic acid containing compounds by UDP- glucuronosyltransferase isoforms. Arch. Biochem. Biophys., 2004, 424(2), 219-225. (Pubitemid 38401955)
7. 'Guidance for Industry: Safety testing of Drug Metabolites', Food and Drug Authority of the USA, Feb. 2008. http://www.fda.gov/ CDER/guidance/6897fnl. pdf
8. Walker, G. S.; Atherton, J.; Bauman, J.; Kohl, C.; Lam, W.; Reily, M.; Lou, Z.; Mutlib, A. Determination of Degradation Pathways and Kinetics of Acyl Glucuronides by NMR Spectroscopy. Chem. Res. Toxicol., 2007, 20(6), 876-886. (Pubitemid 47035341)
9. Goto, J.; Murao, N.; Oohashi, J.; Ikegawa, S. Synthesis of bile acid 24-acyl glucuronides. Steroids, 1998, 63(4), 180-185. (Pubitemid 28198937)
10. Baba, A.; Yoshioka, T. Structure-activity relationships for degradation reactions of 1-β-O-acyl glucuronides: kinetic description and prediction of intrinsic electrophilic reactivity under physiological conditions. Chem. Res. Toxicol., 2009, 22(1), 158-172.
11. Corcoran, O.; Mortensen, R. W.; Hansen, S. H.; Troke, J.; Nicholson, J. K. HPLC-1H NMR spectroscopic studies of the reactive α- 1-O-acyl isomer formed during acyl migration of S-naproxen β-1- O-acyl glucuronide. Chem. Res. Toxicol., 2001, 14(10), 1363-1370. (Pubitemid 32983261)
12. Vanderhoeven, S. J.; Troke, J.; Tranter, G. E.; Wilson, I. D.; Nicholson, J. K.; Lindon, J. C. Nuclear magnetic resonance (NMR) and quantitative structure-activity relationship (QSAR) studies on the transacylation reactivity of model 1β-O-acyl glucuronides. II: QSAR modelling of the reaction using both computational and experimental NMR parameters. Xenobiotica, 2004, 34(10), 889-900. (Pubitemid 39648168)
13. Baba, A.; Yoshioka, T. Synthesis of 1-beta-O-acyl glucuronides of diclofenac, mefenamic acid and (S)-naproxen by the chemoselective enzymatic removal of protecting groups from the corresponding methyl acetyl derivatives. Org. Biomol. Chem., 2006, 4(17), 3303-3310. (Pubitemid 44289458)
14. Baba, A.; Yoshioka, T. An improved chemo-enzymatic synthesis of 1-beta-o-acyl glucuronides: Highly chemoselective enzymatic removal of protecting groups from corresponding methyl acetyl derivatives. J. Org. Chem., 2007, 72(25), 9541-9549. (Pubitemid 350231799)
15. Stachulski, A. V.; Harding, J. R.; Lindon, J. C.; Maggs, J. L.; Park, B. K.; Wilson, I. D. Acyl glucuronides: biological activity, chemical reactivity and chemical synthesis. J. Med. Chem., 2006, 49(24), 6931-6945. (Pubitemid 44885980)
16. Gauthier, C.; Legault, J.; Rondeau, S.; Pichette, A. Synthesis of betulinic acid acyl glucuronide for application in anticancer prodrug monotherapy. Tetrahedron Lett., 2009, 50(9), 988-991.
17. Iddon, L. Ph. D. thesis, University of Liverpool, UK, 2009.
18. Meng, X.; Pryde, D. C.; Maggs, J. L.; Planken, S.; Jenkins, R. E.; Peakman, T. M.; Beaumont, K.; Kohl, C.; Park, B. K.; Stachulski, A. V. Cyclization of the acyl glucuronide metabolite of a neutral endopeptidase inhibitor to an electrophilic glutarimide: synthesis, reactivity, and mechanistic analysis. J. Med. Chem., 2007, 50(24), 6165-6176.
19. Thomas, M.; Gesson, J. P.; Papot, S. Efficient regio- and stereoselective synthesis of 1-β-O-glucuronyl carbamates and carbonates from unprotected 1,2,3,4-hydroxyl glucuronates. Synlett, 2007, (12), 1966-1968. (Pubitemid 47204153)
20. Schaefer, W. H. Reaction of primary and secondary amines to form carbamic acid glucuronides. Curr. Drug Metab., 2006, 7(8), 873-881. (Pubitemid 44873712)
21. Alonen, A.; Jansson, J.; Kallonen, S.; Kiriazis, A.; Aitio, O.; Finel, M.; Kostiainen, R. Enzyme-assisted synthesis and structure characterisation of glucuronic acid conjugates of losartan, candesartan and zolarsartan. Bioorg. Chem., 2008, 36(3), 148-155.
22. Dragan, C.-A.; Buchheit, D.; Bischoff, D.; Ebner, T.; Bureik, M. Glucuronide production by whole-cell biotransformation using genetically engineered fission yeast S. pombe. Drug Metab. Dispos., 2010, 38(3), 509-515.
23. Spahn-Langguth, H.; Benet, L. Z. Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev., 1992, 24(1), 5-47.
24. Dickinson, R. G.; King, A. R. Studies on the reactivity of acyl glucuronides-II. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. Biochem. Pharmacol., 1991, 42(12), 2301-2306.
25. Yoshioka, T.; Baba, A. Structureαactivity relationships for the degradation reaction of 1-β-O-acyl glucuronides. part 2: electronic and steric descriptors predicting the reactivity of 1-β-O-acyl glucuronides derived from benzoic acids. Chem. Res. Toxicol., 2009, 22(9), 1559-1569.
26. Hasegawa, H.; Akira, K.; Shinohara, Y.; Kasuya, Y.; Hashimoto, T. Kinetics of intramolecular acyl migration of 1β-O-acyl glucuronides of (R)- and (S)-2-phenylpropionic acids. Biol. Pharm. Bull., 2001, 24(7), 852-855. (Pubitemid 32633499)
27. Ebner, T.; Heinzel, G.; Prox, A.; Beschke, K.; Wachsmuth, H. Disposition and chemical stability of telmisartan 1-Oacylglucuronide. Drug Metab. Dispos., 1999, 27(10), 1143-1149. (Pubitemid 29463600)
28. Shipkova, M.; Armstrong, V. W.; Oellerich, M.; Wieland, E. Acyl glucuronide metabolites: toxicological and analytical implications. Ther. Drug Monit., 2003, 25(1), 1-16. (Pubitemid 36139819)
29. Iddon, L.; Richards, S. E.; Johnson, C. H.; Harding, J. R.; Wilson, I. D.; Nicholson, J. K.; Stachulski, A. V; etc. Org. Biomol. Chem., 2011, 9, 926-934.
30. Kakiyama, G.; Hosoda, A.; Iida, T.; Fujimoto, Y.; Goto, T.; Mano, N.; Goto, J.; Nambara, T. A direct method for the separation and quantification of bile acid acyl glycosides by high-performance liquid chromatography with an evaporative light scattering detector. J. Chromatogr. A, 2006, 1125(1), 112-116. (Pubitemid 44142051)
31. Tang, C. Y.; Hochman, J. H.; Ma, B.; Subramanian, R.; Vyas, K. P. Acyl glucuronidation and glucosidation of a new and selective endothelin ETA receptor antagonist in human liver microsomes. Drug Metab. Dispos., 2003, 31(1), 37-45. (Pubitemid 36735256)
32. Johnson, C. H.; Wilson, I. D.; Harding, J. R.; Stachulski, A. V.; Iddon, L.; Nicholson, J. K.; Lindon, J. C. NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of ibuprofen [(±)-(R, S)-2-(4-isobutylphenyl) propanoic acid], its metabolites, and analogues. Anal. Chem., 2007, 79(22), 8720-8727. (Pubitemid 350171385)
33. Wang, J.; Davis, M.; Li, F.; Azam, F.; Scatina, J.; Talaat, R. A Novel approach for predicting acyl glucuronide reactivity via schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements. Chem. Res. Toxicol., 2004, 17(9), 1206-1216. (Pubitemid 39265876)
34. Kenny, J. R.; Maggs, J. L.; Meng, X.; Sinnott, D.; Clarke, S. E.; Park. B. K.; Stachulski, A. V. Synthesis and characterisation of the acyl glucuronide and hydroxy metabolites of diclofenac. J. Med. Chem., 2004, 47(11), 2816-2825. (Pubitemid 38656734)
35. Obach, S. Glycerolysis of acyl glucuronides as an artefact of in vitro drug metabolism incubations. Drug Metab. Dispos., 2009, 37(8), 1581-1586.
36. Goldkind, L.; Laine, L. A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. Pharmacoepidemiol. Drug Safety, 2006, 15(4), 213-220.
37. Georges, H.; Jarecki, I.; Netter, P.; Magdalou, J.; Lapicque, F. Glycation of human serum albumin by acylglucuronides of nonsteroidal anti-inflammatory drugs of the series of phenylpropionates. Life Sci., 1999, 65(12), PL151-PL156. (Pubitemid 29425972)
38. Ruelius, H.W.; Kirkman, S.K.; Young, E.M.; Janssen, F.W. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. Adv. Exp. Med. Biol., 1986, 197, 431-441.
39. Johnson, C. H.; Karlsson, E.; Sarda, S.; Iddon, L.; Iqbal, M.; Meng, X.; Harding, J. H.; Stachulski, A. V.; Nicholson, J. K.; Wilson, I. D.; Lindon, J. C. Integrated HPLC-MS and 1H-NMR spectroscopic studies on acyl migration reaction kinetics of model drug ester glucuronides. Xenobiotica, 2010, 40(1), 9-23.
40. Bueno, C. J.; Jimenez, M. C.; Miranda, M. A. In Situ Transient Spectroscopy for the Study of Glucuronidase Activity within Serum Albumin. J. Phys. Chem. B, 2009, 113(19), 6861-6865.
41. Akira, K.; Uchijima, T.; Hashimoto, T. Rapid internal acyl migration and protein binding of synthetic probenecid glucuronides. Chem. Res. Toxicol. 2002, 15(6), 765-772. (Pubitemid 34663616)
42. Xue, Y.-J.; Akinsanya, J.B.; Raghavan, N.; Zhang, D. Optimization to eliminate the interference of migration isomers for measuring 1- O-α-acyl glucuronide without extensive chromatographic separation. Rapid Commun. Mass Spectrom., 2008, 22(2), 109-120. (Pubitemid 351156122)
43. Shipkova, M.; Armstrong, V. W.; Oellerich, M.; Wieland, E. Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability. Expert Opin. Drug Metab. Toxicol. 2005, 1(3), 505-526.
44. Shipkova, M.; Beck, H.; Voland, A.; Armstrong, V. W.; Grone, H. J.; Oellerich, M.; Wieland, E. Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue. Proteomics, 2004, 4(9), 2728-2738. (Pubitemid 39202173)
45. Jones, A. E.; Wilson, H. K.; Meath, P.; Meng, X.; Holt, D. W.; Johnston, A.; Oellerich, M.; Armstrong, V. W.; Stachulski, A. V. Convenient syntheses of the in vivo carbohydrate metabolites of mycophenolic acid: reactivity of the acyl glucuronide. Tetrahedron Lett., 2009, 50(35), 4973-4977.
46. Gensburger, O.; Picard, N.; Marquet, P. Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase. Clin. Chem., 2009, 55(5), 986-993.
47. Kumar, S.; Samuel, K.; Subramanian, R.; Braun, M. P.; Stearns, R. A.; Chiu, S.; Evans, D. C.; Baillie, T. A. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. J. Pharmacol. Exper. Ther., 2002, 303(3), 969-978. (Pubitemid 35424378)
48. Naisbitt, D. J.; Sanderson, L. S.; Meng, X. L.; Stachulski, A. V.; Clarke, S. E.; Park, B. K. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol. Lett., 2007, 168(1), 45-50. (Pubitemid 44909720)
49. Grillo, M. P.; Benet, L. Z. Studies on the reactivity of clofibryl-Sacyl- CoA thioester with glutathione in vitro. Drug Metab. Dispos., 2002, 30(1), 55-62. (Pubitemid 34016941)
50. Li, C.; Benet, L. Z.; Grillo, M. P. Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-Acyl-CoA thioester metabolites. Chem. Res. Toxicol., 2002, 15(10), 1309-1317. (Pubitemid 35222201)
51. Osbild, S.; Bour, J.; Maunit, B.; Guillaume, C.; Asensio, C.; Muller, J. F.; Nettler, P.; Kirsch, G.; Bagrel, D.; Lapicque, F.; Battaglia, E. Interaction of the electrophilic ketoprofenyl-glucuronide and ketoprofenyl-coenzyme a conjugates with cytosolic glutathione Stransferases. Drug Metab. Dispos., 2008, 36(2), 260-267. (Pubitemid 351185737)
52. Olsen, J.; Li, C. Z.; Skonberg, C.; Bjornsdottir, I.; Sidenius, U.; Benet, L. Z.; Hansen, S. H. Studies on the metabolism of tolmetin to the chemically-reactive acyl-coenzyme A thioester intermediate in rats. Drug Metab. Dispos., 2007, 35(5), 758-764. (Pubitemid 46641546)
53. Noort, D.; van Zuylen, A.; Fidder, A.; van Ommen, B.; Hulst, A. G. Protein adduct formation by glucuronide adducts of permethrin. Chem. Res. Toxicol., 2008, 21(7), 1396-1406.
54. Southwood, H. T.; De Graaf, Y. C.; McKenzie, P. I.; Miners, J. O.; Burcham, P. C.; Sallustio, B.C. Carboxylic Acid Drug-Induced DNA Nicking in HEK293 Cells Expressing Human UDPGlucuronosyl- transferases: Role of Acyl Glucuronide Metabolites and Glycation Pathways. Chem. Res. Toxicol., 2007, 20(10), 1520-1527. (Pubitemid 350057222)
55. Bailey, M. J.; Dickinson, R. G. Acyl glucuronide reactivity in perspective: biological consequences. Chem. Biol. Interact., 2003, 145(2), 117-137. (Pubitemid 36398426)